SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance

por Zhang, Xiantao, Wu, Shijian, Wu, Bolin, Yang, Qirui, Chen, Achun, Li, Yuzhuang, Zhang, Yiwen, Pan, Ting, Zhang, Hui, He, Xin
Publicado 2021

Antibody response and cross-neutralization after Omicron BA.2 infection

por Zhang, Yiwen, Li, Rong, Li, Yuzhuang, Yang, Hong, Zhou, Liqiong, Yuan, Jing, Pan, Ting, Liu, Bingfeng, Zhang, Hui, He, Yaqing
Publicado 2023

The interferon-stimulated exosomal hACE2 potently inhibits SARS-CoV-2 replication through competitively blocking the virus entry

por Zhang, Junsong, Huang, Feng, Xia, Baijin, Yuan, Yaochang, Yu, Fei, Wang, Guanwen, Chen, Qianyu, Wang, Qian, Li, Yuzhuang, Li, Rong, Song, Zheng, Pan, Ting, Chen, Jingliang, Lu, Gen, Zhang, Hui
Publicado 2021

Amino acids and RagD potentiate mTORC1 activation in CD8(+) T cells to confer antitumor immunity

por Zhang, Yiwen, Hu, Hongrong, Liu, Weiwei, Yan, Shu-Mei, Li, Yuzhuang, Tan, Likai, Chen, Yingshi, Liu, Jun, Peng, Zhilin, Yuan, Yaochang, Huang, Wenjing, Yu, Fei, He, Xin, Li, Bo, Zhang, Hui
Publicado 2021

Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment

por Xia, Baijin, Lin, Keming, Wang, Xuemei, Chen, FeiLi, Zhou, Mo, Li, Yuzhuang, Lin, Yingtong, Qiao, Yidan, Li, Rong, Zhang, Wanying, He, Xin, Zou, Fan, Li, Linghua, Lu, Lijuan, Chen, Cancan, Li, WenYu, Zhang, Hui, Liu, Bingfeng
Publicado 2023

Brd4 Regulates the Homeostasis of CD8(+) T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation

por Peng, Zhilin, Zhang, Yiwen, Ma, Xiancai, Zhou, Mo, Wu, Shiyu, Song, Zheng, Yuan, Yaochang, Chen, Yingshi, Li, Yuzhuang, Wang, Guanwen, Huang, Feng, Qiao, Yidan, Xia, Baijing, Liu, Weiwei, Liu, Jun, Zhang, Xu, He, Xin, Pan, Ting, Xu, Hanshi, Zhang, Hui
Publicado 2021

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι

por Zhang, Yiwen, Chen, Yingshi, Li, Yuzhuang, Huang, Feng, Luo, Baohong, Yuan, Yaochang, Xia, Baijin, Ma, Xiancai, Yang, Tao, Yu, Fei, Liu, Jun, Liu, Bingfeng, Song, Zheng, Chen, Jingliang, Yan, Shumei, Wu, Liyang, Pan, Ting, Zhang, Xu, Li, Rong, Huang, Wenjing, He, Xin, Xiao, Fei, Zhang, Junsong, Zhang, Hui
Publicado 2021

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

por Ma, Xiancai, Zou, Fan, Yu, Fei, Li, Rong, Yuan, Yaochang, Zhang, Yiwen, Zhang, Xiantao, Deng, Jieyi, Chen, Tao, Song, Zheng, Qiao, Yidan, Zhan, Yikang, Liu, Jun, Zhang, Junsong, Zhang, Xu, Peng, Zhilin, Li, Yuzhuang, Lin, Yingtong, Liang, Liting, Wang, Guanwen, Chen, Yingshi, Chen, Qier, Pan, Ting, He, Xin, Zhang, Hui
Publicado 2020

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2

por Yuan, Yaochang, Zhang, Xiantao, Chen, Ran, Li, Yuzhuang, Wu, Bolin, Li, Rong, Zou, Fan, Ma, Xiancai, Wang, Xuemei, Chen, Qier, Deng, Jieyi, Zhang, Yongli, Chen, Tao, Lin, Yingtong, Yan, Shumei, Zhang, Xu, Li, Congrong, Bu, Xiuqing, Peng, Yi, Ke, Changwen, Deng, Kai, Pan, Ting, He, Xin, Zhang, Yiwen, Zhang, Hui
Publicado 2022

Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants

por Chen, Ran, Zhang, Xiantao, Yuan, Yaochang, Deng, Xiaohui, Wu, Bolin, Xi, Zhihui, Wang, Guanwen, Lin, Yingtong, Li, Rong, Wang, Xuemei, Zou, Fan, Liang, Liting, Yan, Haiping, Liang, Chaofeng, Li, Yuzhuang, Wu, Shijian, Deng, Jieyi, Zhou, Mo, Zhang, Xu, Li, Congrong, Bu, Xiuqing, Peng, Yi, Ke, Changwen, Deng, Kai, He, Xin, Zhang, Yiwen, Zhang, Zhenhai, Pan, Ting, Zhang, Hui
Publicado 2022